ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Chorionic Gonadotropin Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-11U15413
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Chorionic Gonadotropin Market Research Report 2023
BUY CHAPTERS

Global Recombinant Human Chorionic Gonadotropin Market Research Report 2025

Code: QYRE-Auto-11U15413
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ferring Pharmaceuticals
Schering Plough
Merck
Wellona Pharma
Facmed Pharmaceuticals
Serum International Ltd
Bionomics Lifesciences
Marvel Oceanic Private Limited

Recombinant Human Chorionic Gonadotropin Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Recombinant Human Chorionic Gonadotropin Market

Recombinant Human Chorionic Gonadotropin Market

The global market for Recombinant Human Chorionic Gonadotropin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Chorionic Gonadotropin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Chorionic Gonadotropin.
The Recombinant Human Chorionic Gonadotropin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Chorionic Gonadotropin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Chorionic Gonadotropin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Human Chorionic Gonadotropin Market Report

Report Metric Details
Report Name Recombinant Human Chorionic Gonadotropin Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
  • Female
  • Male
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ferring Pharmaceuticals, Schering Plough, Serum International Ltd, Merck, Wellona Pharma, Bionomics Lifesciences, Marvel Oceanic Private Limited, Facmed Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Human Chorionic Gonadotropin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Human Chorionic Gonadotropin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Human Chorionic Gonadotropin Market report?

Ans: The main players in the Recombinant Human Chorionic Gonadotropin Market are Ferring Pharmaceuticals, Schering Plough, Serum International Ltd, Merck, Wellona Pharma, Bionomics Lifesciences, Marvel Oceanic Private Limited, Facmed Pharmaceuticals

What are the Application segmentation covered in the Recombinant Human Chorionic Gonadotropin Market report?

Ans: The Applications covered in the Recombinant Human Chorionic Gonadotropin Market report are Female, Male

What are the Type segmentation covered in the Recombinant Human Chorionic Gonadotropin Market report?

Ans: The Types covered in the Recombinant Human Chorionic Gonadotropin Market report are Intramuscular Powder for Injection, Subcutaneous Solution for Injection

Recommended Reports

Reproductive Health Markets

Diagnostics & Monitoring

Blood & Protein Markets

1 Recombinant Human Chorionic Gonadotropin Market Overview
1.1 Product Definition
1.2 Recombinant Human Chorionic Gonadotropin by Type
1.2.1 Global Recombinant Human Chorionic Gonadotropin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Intramuscular Powder for Injection
1.2.3 Subcutaneous Solution for Injection
1.3 Recombinant Human Chorionic Gonadotropin by Application
1.3.1 Global Recombinant Human Chorionic Gonadotropin Market Value by Application (2024 VS 2031)
1.3.2 Female
1.3.3 Male
1.4 Global Recombinant Human Chorionic Gonadotropin Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Chorionic Gonadotropin Revenue 2020-2031
1.4.2 Global Recombinant Human Chorionic Gonadotropin Sales 2020-2031
1.4.3 Global Recombinant Human Chorionic Gonadotropin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Human Chorionic Gonadotropin Market Competition by Manufacturers
2.1 Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Human Chorionic Gonadotropin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Human Chorionic Gonadotropin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Chorionic Gonadotropin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Chorionic Gonadotropin, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Chorionic Gonadotropin, Date of Enter into This Industry
2.8 Global Recombinant Human Chorionic Gonadotropin Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Chorionic Gonadotropin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Chorionic Gonadotropin Players Market Share by Revenue
2.8.3 Global Recombinant Human Chorionic Gonadotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Chorionic Gonadotropin Market Scenario by Region
3.1 Global Recombinant Human Chorionic Gonadotropin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Human Chorionic Gonadotropin Sales by Region: 2020-2031
3.2.1 Global Recombinant Human Chorionic Gonadotropin Sales by Region: 2020-2025
3.2.2 Global Recombinant Human Chorionic Gonadotropin Sales by Region: 2026-2031
3.3 Global Recombinant Human Chorionic Gonadotropin Revenue by Region: 2020-2031
3.3.1 Global Recombinant Human Chorionic Gonadotropin Revenue by Region: 2020-2025
3.3.2 Global Recombinant Human Chorionic Gonadotropin Revenue by Region: 2026-2031
3.4 North America Recombinant Human Chorionic Gonadotropin Market Facts & Figures by Country
3.4.1 North America Recombinant Human Chorionic Gonadotropin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Human Chorionic Gonadotropin Sales by Country (2020-2031)
3.4.3 North America Recombinant Human Chorionic Gonadotropin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Chorionic Gonadotropin Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Chorionic Gonadotropin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Human Chorionic Gonadotropin Sales by Country (2020-2031)
3.5.3 Europe Recombinant Human Chorionic Gonadotropin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Chorionic Gonadotropin Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Chorionic Gonadotropin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Human Chorionic Gonadotropin Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Human Chorionic Gonadotropin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Chorionic Gonadotropin Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Chorionic Gonadotropin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Human Chorionic Gonadotropin Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Human Chorionic Gonadotropin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Human Chorionic Gonadotropin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Chorionic Gonadotropin Sales by Type (2020-2031)
4.1.1 Global Recombinant Human Chorionic Gonadotropin Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Chorionic Gonadotropin Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Human Chorionic Gonadotropin Revenue by Type (2020-2031)
4.2.1 Global Recombinant Human Chorionic Gonadotropin Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Chorionic Gonadotropin Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Human Chorionic Gonadotropin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Human Chorionic Gonadotropin Sales by Application (2020-2031)
5.1.1 Global Recombinant Human Chorionic Gonadotropin Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Chorionic Gonadotropin Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Human Chorionic Gonadotropin Revenue by Application (2020-2031)
5.2.1 Global Recombinant Human Chorionic Gonadotropin Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Chorionic Gonadotropin Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Human Chorionic Gonadotropin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ferring Pharmaceuticals
6.1.1 Ferring Pharmaceuticals Company Information
6.1.2 Ferring Pharmaceuticals Description and Business Overview
6.1.3 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Portfolio
6.1.5 Ferring Pharmaceuticals Recent Developments/Updates
6.2 Schering Plough
6.2.1 Schering Plough Company Information
6.2.2 Schering Plough Description and Business Overview
6.2.3 Schering Plough Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Schering Plough Recombinant Human Chorionic Gonadotropin Product Portfolio
6.2.5 Schering Plough Recent Developments/Updates
6.3 Serum International Ltd
6.3.1 Serum International Ltd Company Information
6.3.2 Serum International Ltd Description and Business Overview
6.3.3 Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Serum International Ltd Recombinant Human Chorionic Gonadotropin Product Portfolio
6.3.5 Serum International Ltd Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Recombinant Human Chorionic Gonadotropin Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Wellona Pharma
6.5.1 Wellona Pharma Company Information
6.5.2 Wellona Pharma Description and Business Overview
6.5.3 Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wellona Pharma Recombinant Human Chorionic Gonadotropin Product Portfolio
6.5.5 Wellona Pharma Recent Developments/Updates
6.6 Bionomics Lifesciences
6.6.1 Bionomics Lifesciences Company Information
6.6.2 Bionomics Lifesciences Description and Business Overview
6.6.3 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product Portfolio
6.6.5 Bionomics Lifesciences Recent Developments/Updates
6.7 Marvel Oceanic Private Limited
6.7.1 Marvel Oceanic Private Limited Company Information
6.7.2 Marvel Oceanic Private Limited Description and Business Overview
6.7.3 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product Portfolio
6.7.5 Marvel Oceanic Private Limited Recent Developments/Updates
6.8 Facmed Pharmaceuticals
6.8.1 Facmed Pharmaceuticals Company Information
6.8.2 Facmed Pharmaceuticals Description and Business Overview
6.8.3 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Portfolio
6.8.5 Facmed Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Chorionic Gonadotropin Industry Chain Analysis
7.2 Recombinant Human Chorionic Gonadotropin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Chorionic Gonadotropin Production Mode & Process Analysis
7.4 Recombinant Human Chorionic Gonadotropin Sales and Marketing
7.4.1 Recombinant Human Chorionic Gonadotropin Sales Channels
7.4.2 Recombinant Human Chorionic Gonadotropin Distributors
7.5 Recombinant Human Chorionic Gonadotropin Customer Analysis
8 Recombinant Human Chorionic Gonadotropin Market Dynamics
8.1 Recombinant Human Chorionic Gonadotropin Industry Trends
8.2 Recombinant Human Chorionic Gonadotropin Market Drivers
8.3 Recombinant Human Chorionic Gonadotropin Market Challenges
8.4 Recombinant Human Chorionic Gonadotropin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Ferring Pharmaceuticals
Schering Plough
Merck
Wellona Pharma
Facmed Pharmaceuticals
Serum International Ltd
Bionomics Lifesciences
Marvel Oceanic Private Limited
List of Tables
 Table 1. Global Recombinant Human Chorionic Gonadotropin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Human Chorionic Gonadotropin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Human Chorionic Gonadotropin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Human Chorionic Gonadotropin Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Human Chorionic Gonadotropin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Human Chorionic Gonadotropin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Human Chorionic Gonadotropin Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Human Chorionic Gonadotropin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Human Chorionic Gonadotropin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Chorionic Gonadotropin, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Human Chorionic Gonadotropin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Chorionic Gonadotropin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Chorionic Gonadotropin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Chorionic Gonadotropin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Human Chorionic Gonadotropin Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Human Chorionic Gonadotropin Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Human Chorionic Gonadotropin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Human Chorionic Gonadotropin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Human Chorionic Gonadotropin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Human Chorionic Gonadotropin Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Human Chorionic Gonadotropin Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Human Chorionic Gonadotropin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Human Chorionic Gonadotropin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Human Chorionic Gonadotropin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Human Chorionic Gonadotropin Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Human Chorionic Gonadotropin Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Human Chorionic Gonadotropin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Human Chorionic Gonadotropin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Human Chorionic Gonadotropin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Chorionic Gonadotropin Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Human Chorionic Gonadotropin Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Human Chorionic Gonadotropin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Human Chorionic Gonadotropin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Human Chorionic Gonadotropin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Human Chorionic Gonadotropin Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Human Chorionic Gonadotropin Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Human Chorionic Gonadotropin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Human Chorionic Gonadotropin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Human Chorionic Gonadotropin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Human Chorionic Gonadotropin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Human Chorionic Gonadotropin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Human Chorionic Gonadotropin Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Human Chorionic Gonadotropin Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Human Chorionic Gonadotropin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Human Chorionic Gonadotropin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Human Chorionic Gonadotropin Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Human Chorionic Gonadotropin Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Human Chorionic Gonadotropin Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Human Chorionic Gonadotropin Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Human Chorionic Gonadotropin Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Human Chorionic Gonadotropin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Human Chorionic Gonadotropin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Human Chorionic Gonadotropin Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Human Chorionic Gonadotropin Price (US$/Unit) by Application (2026-2031)
 Table 70. Ferring Pharmaceuticals Company Information
 Table 71. Ferring Pharmaceuticals Description and Business Overview
 Table 72. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product
 Table 74. Ferring Pharmaceuticals Recent Developments/Updates
 Table 75. Schering Plough Company Information
 Table 76. Schering Plough Description and Business Overview
 Table 77. Schering Plough Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Schering Plough Recombinant Human Chorionic Gonadotropin Product
 Table 79. Schering Plough Recent Developments/Updates
 Table 80. Serum International Ltd Company Information
 Table 81. Serum International Ltd Description and Business Overview
 Table 82. Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Serum International Ltd Recombinant Human Chorionic Gonadotropin Product
 Table 84. Serum International Ltd Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck Recombinant Human Chorionic Gonadotropin Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Wellona Pharma Company Information
 Table 91. Wellona Pharma Description and Business Overview
 Table 92. Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Wellona Pharma Recombinant Human Chorionic Gonadotropin Product
 Table 94. Wellona Pharma Recent Developments/Updates
 Table 95. Bionomics Lifesciences Company Information
 Table 96. Bionomics Lifesciences Description and Business Overview
 Table 97. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product
 Table 99. Bionomics Lifesciences Recent Developments/Updates
 Table 100. Marvel Oceanic Private Limited Company Information
 Table 101. Marvel Oceanic Private Limited Description and Business Overview
 Table 102. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product
 Table 104. Marvel Oceanic Private Limited Recent Developments/Updates
 Table 105. Facmed Pharmaceuticals Company Information
 Table 106. Facmed Pharmaceuticals Description and Business Overview
 Table 107. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product
 Table 109. Facmed Pharmaceuticals Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Recombinant Human Chorionic Gonadotropin Distributors List
 Table 113. Recombinant Human Chorionic Gonadotropin Customers List
 Table 114. Recombinant Human Chorionic Gonadotropin Market Trends
 Table 115. Recombinant Human Chorionic Gonadotropin Market Drivers
 Table 116. Recombinant Human Chorionic Gonadotropin Market Challenges
 Table 117. Recombinant Human Chorionic Gonadotropin Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Chorionic Gonadotropin
 Figure 2. Global Recombinant Human Chorionic Gonadotropin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Human Chorionic Gonadotropin Market Share by Type: 2024 & 2031
 Figure 4. Intramuscular Powder for Injection Product Picture
 Figure 5. Subcutaneous Solution for Injection Product Picture
 Figure 6. Global Recombinant Human Chorionic Gonadotropin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Human Chorionic Gonadotropin Market Share by Application: 2024 & 2031
 Figure 8. Female
 Figure 9. Male
 Figure 10. Global Recombinant Human Chorionic Gonadotropin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Recombinant Human Chorionic Gonadotropin Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Recombinant Human Chorionic Gonadotropin Sales (2020-2031) & (K Units)
 Figure 13. Global Recombinant Human Chorionic Gonadotropin Average Price (US$/Unit) & (2020-2031)
 Figure 14. Recombinant Human Chorionic Gonadotropin Report Years Considered
 Figure 15. Recombinant Human Chorionic Gonadotropin Sales Share by Manufacturers in 2024
 Figure 16. Global Recombinant Human Chorionic Gonadotropin Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Recombinant Human Chorionic Gonadotropin Players: Market Share by Revenue in Recombinant Human Chorionic Gonadotropin in 2024
 Figure 18. Recombinant Human Chorionic Gonadotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Recombinant Human Chorionic Gonadotropin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Recombinant Human Chorionic Gonadotropin Sales Market Share by Country (2020-2031)
 Figure 21. North America Recombinant Human Chorionic Gonadotropin Revenue Market Share by Country (2020-2031)
 Figure 22. United States Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Recombinant Human Chorionic Gonadotropin Sales Market Share by Country (2020-2031)
 Figure 25. Europe Recombinant Human Chorionic Gonadotropin Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Recombinant Human Chorionic Gonadotropin Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Recombinant Human Chorionic Gonadotropin Revenue Market Share by Region (2020-2031)
 Figure 33. China Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Recombinant Human Chorionic Gonadotropin Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Recombinant Human Chorionic Gonadotropin Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Recombinant Human Chorionic Gonadotropin Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Recombinant Human Chorionic Gonadotropin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Recombinant Human Chorionic Gonadotropin by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Recombinant Human Chorionic Gonadotropin by Type (2020-2031)
 Figure 52. Global Recombinant Human Chorionic Gonadotropin Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Recombinant Human Chorionic Gonadotropin by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Recombinant Human Chorionic Gonadotropin by Application (2020-2031)
 Figure 55. Global Recombinant Human Chorionic Gonadotropin Price (US$/Unit) by Application (2020-2031)
 Figure 56. Recombinant Human Chorionic Gonadotropin Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Human Chorionic Gonadotrophin HCG Market Research Report 2025
Global Chorionic Gonadotropin for Injection Market Research Report 2025
Recombinant Human Osteopontin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproductive Medical Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Growth Hormone Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pregnancy Risk Calculation Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human VEGF Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
IVF Workstations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Genomic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Human Procalcitonin Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Enterokinase Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Gynecological Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gynecological Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematopoietic Stem Cell Transplantation HSCT Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Recombinant Growth Factors Market Research Report 2025
Single Use Equipment for Biopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Precision Medicine Market
Biopharmaceutical Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Whole Blood Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions